顯示第 33 至 48 項結果，共 81 項
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-1.1-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-1.1)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-10.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-10.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-10.3-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-10.3)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-2.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-2.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-23.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-23.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0)